Market Cap
Thermo Fisher Scientific Inc.
$207.62 Billion
USD as of Jan. 1, 2024
Company | Market Cap (USD) |
---|---|
Danaher | $171.89 B |
Siemens Healthineers AG | $66.05 B |
DexCom, Inc. | $46.50 B |
IDEXX Laboratories, Inc. | $44.72 B |
IQVIA Holdings Inc. | $40.16 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Thermo Fisher Scientific Inc. dedicated to biological and medical diagnostics and research. It manufactures and distributes scientific and medical instruments, laboratory equipment, software, reagents, consumables, chemicals, and services. Segmented into life sciences, analytical instruments, specialty diagnostics, and laboratory products, Thermo Fisher caters to the needs of multiple pharmaceuticals, biotechnology, agricultural, clinical, academic, and government actors.
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.